What is the 1st line of treatment for colorectal cancer

Q: What is the 1st line of treatment for colorectal cancer

According to the NCCN National Comprehensive Cancer Network Guidelines for Colorectal Cancer 2023, the first-line treatment depends primarily on the stage of cancer at diagnosis: For Early-Stage Colorectal Cancer Stage I-III: - Surgery is typically the primary first-line treatment - For stage III and some high-risk stage II patients, adjuvant chemotherapy follows surgery For Stage IV Metastatic Colorectal Cancer: The American Society of Clinical Oncology ASCO Guidelines recommend: 1. Molecular t

October 28, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case. No signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Built by OpenCancer’s team of physician-scientists and cancer survivors.
Last updated October 28, 2025. Informational only — not a substitute for your oncology team.

According to the NCCN (National Comprehensive Cancer Network) Guidelines for Colorectal Cancer (2023), the first-line treatment depends primarily on the stage of cancer at diagnosis:

For Early-Stage Colorectal Cancer (Stage I-III):

Surgery is typically the primary first-line treatment
For stage III and some high-risk stage II patients, adjuvant chemotherapy follows surgery

For Stage IV (Metastatic) Colorectal Cancer: The American Society of Clinical Oncology (ASCO) Guidelines recommend:

Molecular testing of the tumor for:

RAS mutations (KRAS/NRAS)
BRAF mutations
MSI (microsatellite instability) status

Based on these results, first-line treatment typically includes:

For RAS wild-type tumors: Chemotherapy (FOLFOX or FOLFIRI) plus targeted therapy (like cetuximab or bevacizumab)
For RAS-mutated tumors: Chemotherapy plus bevacizumab

The National Cancer Institute (NCI) emphasizes that treatment plans should be individualized based on:

Cancer stage
Location of the tumor
Genetic markers
Patient's overall health
Patient preferences

Always consult with your oncology team for specific treatment recommendations, as they will consider your individual case characteristics and preferences.

Ask Navis about your case

That answer is general. Ask about your specific situation. No signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →